Skip to content
Advertisement

James Teague, president of AstraZeneca's in Thailand attends a signing ceremony at Government House in Bangkok, Thailand Friday, Nov. 27, 2020. Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. (Chalinee Thirasupa/Pool Photo via AP)

James Teague, president of AstraZeneca's in Thailand attends a signing ceremony at Government House in Bangkok, Thailand Friday, Nov. 27, 2020. Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. (Chalinee Thirasupa/Pool Photo via AP)

Featured Photo Galleries